Primary |
Product Used For Unknown Indication |
58.9% |
Drug Use For Unknown Indication |
18.4% |
Depression |
5.3% |
Pain |
3.7% |
Psychotic Disorder |
3.2% |
Toothache |
2.6% |
Accidental Overdose |
1.6% |
Drug Abuser |
1.6% |
Pain In Extremity |
1.6% |
Anxiety |
0.5% |
Major Depression |
0.5% |
Mental Disorder |
0.5% |
Multiple Sclerosis |
0.5% |
Neuropathy Peripheral |
0.5% |
Prophylaxis |
0.5% |
|
Completed Suicide |
38.0% |
Cardio-respiratory Arrest |
6.0% |
Accidental Overdose |
4.0% |
Brugada Syndrome |
4.0% |
Drug Exposure During Pregnancy |
4.0% |
Intentional Overdose |
4.0% |
Overdose |
4.0% |
Pulmonary Embolism |
4.0% |
Respiratory Depression |
4.0% |
Sinus Bradycardia |
4.0% |
Toxicity To Various Agents |
4.0% |
Ventricular Tachycardia |
4.0% |
Abortion Spontaneous |
2.0% |
Carbon Monoxide Poisoning |
2.0% |
Death |
2.0% |
Delirium |
2.0% |
Drug Abuse |
2.0% |
Drug Interaction |
2.0% |
Drug Toxicity |
2.0% |
Electrocardiogram Qt Prolonged |
2.0% |
|
Secondary |
Product Used For Unknown Indication |
25.9% |
Drug Use For Unknown Indication |
12.0% |
Depression |
10.8% |
Ill-defined Disorder |
6.6% |
Pain |
6.6% |
Psychotic Disorder |
6.0% |
Drug Use For Unknown Indication |
4.2% |
Alcoholic Seizure |
4.2% |
Bipolar Disorder |
4.2% |
Movement Disorder |
4.2% |
Headache |
3.0% |
Neuralgia |
3.0% |
Anxiety |
1.8% |
Neuropathy Peripheral |
1.8% |
Suicide Attempt |
1.8% |
Trigeminal Neuralgia |
1.2% |
Back Pain |
0.6% |
Constipation |
0.6% |
Gastrooesophageal Reflux Disease |
0.6% |
Hypothyroidism |
0.6% |
|
Death |
17.1% |
Completed Suicide |
12.2% |
Swelling |
9.8% |
Toxicity To Various Agents |
9.8% |
Brugada Syndrome |
4.9% |
Dyspnoea Exertional |
4.9% |
Neurotoxicity |
4.9% |
Syncope |
4.9% |
White Blood Cell Count Increased |
4.9% |
Blood Sodium Decreased |
2.4% |
Cardiac Arrest |
2.4% |
Hyperprolactinaemia |
2.4% |
Inappropriate Antidiuretic Hormone Secretion |
2.4% |
Micturition Frequency Decreased |
2.4% |
Neuropathy Peripheral |
2.4% |
Overdose |
2.4% |
Panic Attack |
2.4% |
Restlessness |
2.4% |
Sopor |
2.4% |
Spinal Compression Fracture |
2.4% |
|
Concomitant |
Product Used For Unknown Indication |
29.8% |
Drug Use For Unknown Indication |
14.0% |
Pain |
7.7% |
Depression |
7.1% |
Rheumatoid Arthritis |
4.8% |
Anxiety |
4.5% |
Hypertension |
3.4% |
Asthma |
3.1% |
Acne |
2.9% |
Migraine |
2.7% |
Gastrooesophageal Reflux Disease |
2.6% |
Insomnia |
2.5% |
Blood Pressure |
2.3% |
Headache |
2.2% |
Constipation |
2.1% |
Back Pain |
1.8% |
Bipolar Disorder |
1.6% |
Diabetes Mellitus |
1.6% |
Multiple Sclerosis |
1.6% |
Sleep Disorder |
1.6% |
|
Weight Decreased |
14.9% |
Fall |
6.8% |
Pain |
6.8% |
Somnolence |
5.4% |
Tooth Extraction |
5.4% |
Type 2 Diabetes Mellitus |
5.4% |
Vomiting |
5.4% |
Anxiety |
4.1% |
Cholelithiasis |
4.1% |
Death |
4.1% |
Drug Level Increased |
4.1% |
Dysphagia |
4.1% |
Injection Site Pain |
4.1% |
Pain In Extremity |
4.1% |
Renal Failure Acute |
4.1% |
Toxicity To Various Agents |
4.1% |
Upper Limb Fracture |
4.1% |
Visual Disturbance |
4.1% |
Bradycardia |
2.7% |
Diabetic Ketoacidosis |
2.7% |
|
Interacting |
|
Overdose |
50.0% |
Pyrexia |
50.0% |
|